Analyst Ratings for Navidea Biopharmaceuticals (NAVB) [Neutrals]

All Latest Ratings for NAVB

NAVB Rating Summary

NAVB Price Target Summary

  |   Expand Research on NAVB
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $3.67 (+53.4%)
Date Firm Type Rating
(Past)		 PT
(Past)		 Start $ End $ % Chg. Details
1/22/2013 Aegis Capital New Coverage Hold
(N/A)		 3.00
(N/A)		 2.97 2.39 -19.53% Details
9/11/2012 ThinkEquity Downgrade Hold
(Buy)		 2.50
(N/A)		 3.51 2.39 -31.91% Details
Like NAVB Ratings? Also take a look at NDN, NDZ, LTS, CAH

NAVB Ratings News